MedTrace Logo

Exercise Induced Bronchospasm in Children

NCT00273689 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2008-05-07

No results posted yet for this study

Summary

The purpose of the study is to test how well 2 different medications stop asthma symptoms caused by exercising. The two medications that will be tested are "pretreatment with albuterol" and montelukast (Singulair®). Although both medications are used for treating asthma, we don't know which medicine is better at stopping asthma symptoms caused by exercising.

Conditions

  • Exercise Induced Bronchospasm

Interventions

DRUG

montelukast vs pretreatment with albuterol

montelukast 5 or 10 mg once daily for 3 days vs albuterol 2 puffs, 15 minutes before exercise

DRUG

montelukast

Montelukast 5 or 10 mg once daily for 3 days vs Albuterol inhlare 2 puffs, 15 minutes before exercise

Sponsors & Collaborators

  • American College of Clinical Pharmacy

    collaborator OTHER

  • University of New Mexico

    lead OTHER

Principal Investigators

  • Hengameh H Raissy, PharmD · University of New Mexico

  • William Kelly, PharmD · University of New Mexico

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
7 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2007-09-30
Completion
2007-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00273689 on ClinicalTrials.gov